BIO-key International (BKYI) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached $1.61M, up 10% sequentially but down 25–26% year-over-year due to a large prior-year contract; growth driven by transition to high-margin branded products in EMEA and new deployments in education and defense sectors.

• Major customer upgraded to advanced biometric authentication, contributing $690K in Q1 and expected to double to $3M over the next two years starting Q1 2026.

• Strategic partnerships, including California EdTech JPA and Arrow ECS Iberia, expanded access to K-12 and EMEA markets.

• Strong traction in defense, financial services, and education sectors, with new deployments at National Bank of Egypt, Wyoming Department of Education, and international defense agencies.

• The company operates a SaaS model with recurring revenue from software subscriptions and hardware sales, focusing on regulated industries and global expansion.

Financial highlights

• Q1 2025 revenue: $1.61M, down from $2.18M in Q1 2024 year-over-year, but up 10% sequentially from Q4 2024.

• Gross margin: 82.6% in Q1 2025 vs. 86.3% in Q1 2024; gross profit $1.33M vs. $1.88M prior year.

• Net loss: $736.5K ($0.16/share) vs. $510.3K ($0.32/share) in Q1 2024, on 4.7M vs. 1.6M shares outstanding.

• Cash and cash equivalents rose to $3.13M at March 31, 2025, from $437.6K at year-end 2024, primarily due to $3.8M in warrant exercises.

• Hardware revenue surged to $236K from $18K year-over-year, driven by expanded biometric scanner sales.

Outlook and guidance

• Management expects sequential revenue growth through 2025, with possible Q3 seasonality impact in EMEA and license revenue acceleration as EMEA transitions to BIO-key products.

• Large customer renewal in Q1 2026 anticipated at $3M for two years; defense sector deals seen as potential game changers.

• Gross margin targeted at 80%+; operating expenses expected to remain controlled with minor seasonal increases.

• The company may need additional financing within 12 months if revenue or inventory liquidation is insufficient.

• Financial performance may fluctuate quarter-to-quarter due to timing of large orders or renewals.